FindTrial
Sign In

A real-world study of COVID-19 in lower limb deep venous thrombosis in patients with hip and knee osteoarthritis (OA) in mainland China

A real-world study of COVID-19 on deep venous thrombosis in osteoarthritis (OA)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300068858
Enrollment
Unknown
Registered
2023-03-01
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoarthiritis

Interventions

OA patients with COVID-19 infection vs. OA patients without COVID-19 infection:Nil

Sponsors

1st Hospital of Soochow Univ.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Age >=40 years old (2) Patients diagnosed with hip and knee osteoarthritis (OA) (3) Able to understand and agree to informed consent

Exclusion criteria

Exclusion criteria: (1) Patients with various secondary osteoarthritis, including congenital or developmental diseases. (2) Inflammatory arthritis (systemic lupus erythematosus, rheumatoid arthritis, hemophiliac arthritis, gout, spinal arthritis, etc.) (3) Patients with severe mental illness.

Design outcomes

Primary

MeasureTime frame
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score;Visual Analogue Scale, VAS;SF-36;Wells-Score;Lower extremity venous ultrasound;—

Countries

China

Contacts

Public ContactGuo Jiongjiong

1st Hospital of Soochow Univ.

drjjguo@163.com+86 18013563327

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026